A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect
{{output}}
In 2025, the FDA approved 46 drug marketing applications, 31 of which were small molecule drugs. Despite the advancements in biotechnologies such as antibody drugs, RNA-based treatments, and antibody-drug conjugates, small molecule drugs remain dominant in new... ...
